Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devic…
Medical - Devices
US, Marlborough [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 835.00 | 325.00 | 1,008.00 | 1,260.00 | 1,082.00 | 1,269.00 | 600.00 | 972.00 | 1,426.00 | 310.00 | 1,836.00 | 1,508.00 | 1,870.00 | 1,526.00 | 2,503.00 | |
| Operating Cash (Net) | 835.00 | 325.00 | 1,008.00 | 1,260.00 | 1,082.00 | 1,269.00 | 600.00 | 972.00 | 1,426.00 | 310.00 | 1,836.00 | 1,508.00 | 1,870.00 | 1,526.00 | 2,503.00 | |
| Accounts Receivable | 1.00 | 52.00 | 42.00 | 37.00 | -101.00 | 53.00 | -17.00 | -216.00 | -30.00 | -110.00 | -130.00 | 335.00 | -279.00 | -220.00 | -238.00 | |
| Accounts Payable | 1,016.00 | -1,148.00 | -271.00 | - - | - - | - - | - - | - - | - - | - - | - - | -28.00 | 408.00 | -255.00 | 118.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 922.00 | -1,373.00 | -237.00 | 284.00 | 155.00 | 962.00 | 280.00 | -4.00 | 66.00 | -2,160.00 | -282.00 | 42.00 | -351.00 | -1,005.00 | -770.00 | |
| Other WC | 1,013.00 | -1,420.00 | -225.00 | 181.00 | 263.00 | 990.00 | 294.00 | 172.00 | 203.00 | -1,967.00 | 138.00 | -200.00 | -134.00 | -209.00 | 10.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -793.00 | -480.00 | 769.00 | -579.00 | -475.00 | -745.00 | -2,186.00 | -887.00 | -1,010.00 | -1,921.00 | -5,041.00 | -411.00 | -1,597.00 | -2,011.00 | -2,574.00 | |
| Capital Expenditure | -362.00 | -278.00 | -304.00 | -226.00 | -245.00 | -259.00 | -247.00 | -376.00 | -319.00 | -316.00 | -461.00 | -376.00 | -554.00 | -612.00 | -800.00 | |
| Purchases of Investments | - - | - - | -11.00 | -22.00 | -44.00 | -26.00 | -266.00 | -132.00 | -131.00 | -172.00 | -348.00 | -146.00 | 96.00 | 24.00 | -55.00 | |
| Sale/Maturity of Investment | 91.00 | 4.00 | 5.00 | 9.00 | 5.00 | 14.00 | 61.00 | - - | - - | 14.00 | 59.00 | 12.00 | 294.00 | 56.00 | 2.00 | |
| Property, Plant, Equipment (P&PE) | -362.00 | -278.00 | -304.00 | -226.00 | -245.00 | -259.00 | -247.00 | -376.00 | -319.00 | -316.00 | -461.00 | -376.00 | -554.00 | -612.00 | -800.00 | |
| Acquisitions (Net) | -527.00 | -211.00 | 1,063.00 | -356.00 | -244.00 | -474.00 | -1,734.00 | -408.00 | -560.00 | -1,448.00 | -4,292.00 | 12.00 | -1,432.00 | -1,537.00 | -1,811.00 | |
| Other Investing Activities | -45.00 | -1.00 | 32.00 | 32.00 | 106.00 | - - | -205.00 | 29.00 | -131.00 | 1.00 | 1.00 | 87.00 | -1.00 | 58.00 | 90.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -820.00 | -496.00 | -1,721.00 | -744.00 | -596.00 | -150.00 | -1,322.00 | -206.00 | -110.00 | -1,432.00 | -2,973.00 | -293.00 | -95.00 | -548.00 | -5.00 | |
| Debt Repayment | -2,825.00 | -1,700.00 | -1,815.00 | -390.00 | -1,790.00 | -810.00 | -1,715.00 | -820.00 | -3,216.00 | -1,171.00 | -4,560.00 | -6,843.00 | - - | -3,435.00 | -4.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -28.00 | -55.00 | -55.00 | -28.00 | |
|
Common Stock
|
- - | - - | 513 | 621 | 574 | 185 | - - | - - | - - | - - | - - | 1,510 | - - | - - | - - | |
| Issued | 33.00 | 31.00 | 21.00 | 21.00 | 74.00 | 60.00 | 114.00 | 111.00 | 85.00 | 101.00 | 123.00 | 975.00 | - - | - - | - - | |
| Repurchased | - - | - - | -492.00 | -600.00 | -500.00 | -125.00 | - - | - - | - - | - - | - - | -535.00 | - - | - - | - - | |
| Other Financing Activities | 1,972.00 | 1,173.00 | 565.00 | 225.00 | 1,620.00 | 725.00 | 2,923.00 | 503.00 | 3,241.00 | 2,502.00 | 7,410.00 | 6,724.00 | -40.00 | 2,942.00 | 37.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 1,641.00 | 864.00 | 213.00 | 267.00 | 207.00 | 217.00 | 587.00 | 319.00 | 487.00 | 1,017.00 | 829.00 | 607.00 | 1,995.00 | 2,168.00 | 1,126.00 | |
| End of Period | 864.00 | 213.00 | 267.00 | 207.00 | 217.00 | 587.00 | 319.00 | 196.00 | 1,017.00 | 829.00 | 607.00 | 1,995.00 | 2,168.00 | 1,126.00 | 1,055.00 | |
| Change | -777.00 | -651.00 | 54.00 | -60.00 | 10.00 | 370.00 | -268.00 | -123.00 | 530.00 | -188.00 | -222.00 | 1,388.00 | 173.00 | -1,042.00 | -71.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 834.00 | 816.00 | 717.00 | 683.00 | 689.00 | 725.00 | 769.00 | 815.00 | 844.00 | 894.00 | 1,011.00 | 1,123.00 | 1,093.00 | 1,136.00 | 1,196.00 | |
| Stock Based Compensation | - - | - - | - - | - - | 105.00 | 103.00 | 107.00 | 116.00 | 128.00 | - - | 157.00 | 170.00 | 194.00 | 220.00 | 233.00 | |
| Other | 48.00 | 1,907.00 | 354.00 | 4,419.00 | 477.00 | -5.00 | 215.00 | 3.00 | 40.00 | -148.00 | 551.00 | 337.00 | 17.00 | 540.00 | 253.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | 473.00 | 47.00 | 704.00 | 1,034.00 | 837.00 | 1,010.00 | 353.00 | 596.00 | 1,107.00 | -6.00 | 1,375.00 | 1,132.00 | 1,316.00 | 914.00 | 1,703.00 | |
| Cash Conversion Cycle (CCC) | 161.00 | 161.00 | 159.00 | 156.00 | 169.00 | 166.00 | 193.00 | 138.00 | 137.00 | 163.00 | 184.00 | 143.00 | 133.00 | 148.00 | 186.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | 1.00 | - - | -2.00 | 3.00 | -1.00 | -4.00 | -4.00 | -2.00 | 4.00 | -8.00 | 10.00 | -2.00 | -6.00 | -9.00 | -4.00 |